obinutuzumab
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
obinutuzumab
Summary
obinutuzumab is a type of chemical entity[1]. obinutuzumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (120 views/month).[2]
Key Facts
- obinutuzumab's instance of is recorded as type of chemical entity[3].
- obinutuzumab's CAS Registry Number is recorded as 949142-50-1[4].
- obinutuzumab's ATC code is recorded as L01XC15[5].
- obinutuzumab's chemical formula is recorded as C₆₅₁₂H₁₀₀₆₀N₁₇₁₂O₂₀₂₀S₄₄[6].
- obinutuzumab's subclass of is recorded as chemical compound[7].
- obinutuzumab's has use is recorded as medication[8].
- obinutuzumab's MeSH descriptor ID is recorded as C543332[9].
- obinutuzumab's ChEMBL ID is recorded as CHEMBL1743048[10].
- obinutuzumab's Guide to Pharmacology Ligand ID is recorded as 6941[11].
- obinutuzumab's Freebase ID is recorded as /m/04q2lbw[12].
- obinutuzumab's UNII is recorded as O43472U9X8[13].
- obinutuzumab's KEGG ID is recorded as D09321[14].
- obinutuzumab's DrugBank ID is recorded as DB08935[15].
- obinutuzumab's has characteristic is recorded as biopharmaceutical[16].
- obinutuzumab's HSDB ID is recorded as 8249[17].
- obinutuzumab's NDF-RT ID is recorded as N0000189499[18].
- obinutuzumab's medical condition treated is recorded as mantle cell lymphoma[19].
- obinutuzumab's medical condition treated is recorded as B-cell lymphoma[20].
- obinutuzumab's medical condition treated is recorded as non-Hodgkin lymphoma[21].
- obinutuzumab's medical condition treated is recorded as diffuse large B-cell lymphoma[22].
- obinutuzumab's medical condition treated is recorded as chronic lymphocytic leukemia[23].
- obinutuzumab's subject has role is recorded as immunological antineoplastic agent[24].
- obinutuzumab's subject has role is recorded as monoclonal antibody[25].
- obinutuzumab's RxNorm CUI is recorded as 974779[26].
- obinutuzumab's World Health Organisation international non-proprietary name numeric ID is recorded as 9043[27].
Why It Matters
obinutuzumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (120 views/month).[2] obinutuzumab has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[28] obinutuzumab is known by 14 alternative names across languages and contexts.[29]